earticle

논문검색

산업원천기술개발사업 성과발표회 : 좌장: 김승욱 교수(고려대학교)

Development of manufacturing process on cell therapy

초록

영어

Bone marrow stromal cells or MSCs exists as a population of cells having the capacity to differentiate into osteogenic, chondrogenic or adipogenic lineages in vitro and in vivo. To utilize the enormous MSCs potential for cartilage injury repair, numerous attempts have been made, including MSC-seeded scaffold and cultured MSCs implantation in vivo. Formation of biological substitute using the concept of tissue engineering generally requires an artificial scaffold. The
three dimensional environment plays an important role in promoting cell-matrix interactions during chondrogenesis and the phenotypic stability of chondrocytes are closely related to their surrounding 3D matrix. The extracellular matrix (ECM) has received significant attention as a functional scaffold in the tissue engineering field, because it can serve not only a physical support but also provide favorable environments for cells. However, the ECM scaffold still requires
many technical improvements to construct artificial tissue suitable for clinical use. So, we developed a novel ECM scaffold fabricated by our proprietary procedure using cultured chondrocyte and focus on ECM application to clinical use. Until now, we apply that novel ECM scaffold and membrane were developed. And, we demonstrated that ECM would confer benefit as a result of cartilage defect after ECM scaffold or membrane implantation.

저자정보

  • Byoung-Hyun Min Department of orthopaedic surgery, School of medicine, Ajou University Cell therapy center, Ajou University

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

      0개의 논문이 장바구니에 담겼습니다.